Fellows

Fellows in Committee on Clinical Pharmacology and Pharmacogenomics

Kunal Desai, MD, MBA, MS

Fellow, Committee on Clinical Pharmacology and Pharmacogenomics

Research Interest: De novo drug discovery in solid tumors; this includes the spectrum – from identifying novel targets to elucidating their mechanism of action to developing novel targeted therapies.

Research Mentors: Russell Szmulewitz, MD

Jacobi Hines, MD

Fellow, Committee on Clinical Pharmacology and Pharmacogenomics

Research Interest: Optimization of cancer immunotherapies; specifically, combination therapies, predicting response and predicting/treating immune related adverse events.

Research Mentors: Pankti Reid, MD and Marina Chiara Garassino, MD.

Nabiel Mir, MD

Fellow, Committee on Clinical Pharmacology and Pharmacogenomics

Research Interest: Early phase clinical trials for vulnerable patients, geriatrics, AI and precision dosing, digital health.

Research Mentor: Russell Szmulewitz, MD

Marcel Bertsch-Gout, MD

Fellow, Committee on Clinical Pharmacology and Pharmacogenomics

Research Interest: Early phase clinical trials; improving the side effect profiles of psychiatric medications by increasing receptor specificity and through pairing with

Research Mentors: Jon E. Grant, JD, MD

Joseph Cannova, MD, PhD

Fellow, Committee on Clinical Pharmacology and Pharmacogenomics

Research Interest: Investigating mechanisms of recurrent cytogenetic alterations in therapy-related myelodysplastic syndrome and acute myeloid leukemia with loss of chromosome 7 domains.

Research Mentors: Megan McNerney, MD, PhD

Youngwoo Cho, PharmD

Fellow, Committee on Clinical Pharmacology and Pharmacogenomics

Research Interest: Translation of pharmacogenomics (PGx) in clinical oncology, early-phase clinical development, and pharmacokinetics (PK) and pharmacodynamics (PD) of immunotherapy

Research Mentor: Peter H. O’Donnell, MD

Sabrina Imam, MD, PhD

Fellow, Committee on Clinical Pharmacology and Pharmacogenomics

Research Interest: Characterizing the intestinal microbiome and metabolome in people undergoing chemotherapy in hopes of identifying metabolites associated with favorable clinical outcomes and protection from infection

Research Mentors: Eric G. Pamer, MD

Danica Quickfall, MDCM

Fellow, Committee on Clinical Pharmacology and Pharmacogenomics

Research Interest: Understanding sedative and antimicrobial administration in critically ill patients. Focus on optimizing antimicrobial dosing in patients receiving continuous renal replacement therapy and novel routes of medication administration

Research Mentors: Jay Koyner, MD

Robert Cameron, MD

Fellow, Committee on Clinical Pharmacology and Pharmacogenomics

Research Interest: Identification of metabolic vulnerabilities within tumors to develop new therapeutic targets and combinations

Research Mentors: Brandon Faubert, PhD and Marina Garassino, MD